Establishing secure connection…Loading editor…Preparing document…

Healthcare Lung Study Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE LUNG STUDY AGREEMENT

This Lung Study Agreement documents voluntary informed consent for participation in the research study identified below. Study Sponsor/Site: Study ID:

Participant Information

Participant Name: Date of Birth:

Insurance Information

Medical History

Chronic Conditions (check all that apply):

Study Procedures and Participation

Purpose and Procedures: The study will evaluate lung structure and function using diagnostic procedures which may include imaging (CT scan), pulmonary function testing (spirometry), blood sampling, symptom questionnaires, and brief clinical examinations. Estimated duration of participation: . Number of study visits: .

I consent to the following study procedures (check all that apply):

Risks, Discomforts, and Benefits

Risks: Procedures may involve risks including radiation exposure from CT imaging, temporary shortness of breath or lightheadedness from spirometry, pain or bruising at blood draw sites, bleeding or infection with invasive procedures, and incidental findings requiring follow-up. There is a possibility of unforeseeable risks. If any procedure-specific risks apply, these have been explained to me.

Benefits: There may be no direct benefit. Potential benefits include information about lung health that may assist clinical care and contribution to medical knowledge that may benefit others.

Participant initials acknowledging review of risks: Radiation risk: Bleeding/infection risk: Discomfort/other risks:

Confidentiality, Use of Data and Specimens

Data and biological specimens collected for this study will be stored securely. Identifiable information will be accessible only to authorized study personnel. De-identified data and samples may be used for future research; such use does not require additional consent if identifiers are removed. I understand that my medical records may be reviewed by authorized monitors and regulatory bodies for verification purposes.

I authorize storage and future research use of my de-identified samples: I authorize use of specimens for genetic analysis: I authorize future research contact:

Compensation and Costs

Compensation for participation, if any, and reimbursement for travel or parking will be provided as described below. I understand routine clinical care costs remain my responsibility unless otherwise stated.

Voluntary Participation and Withdrawal

Participation is voluntary. I may withdraw at any time without penalty or loss of benefits to which I am otherwise entitled. Withdrawal will not affect my right to future clinical care. If I withdraw, data collected prior to withdrawal may remain part of the study unless I request destruction where feasible.

HIPAA Authorization / Privacy Acknowledgment

I acknowledge that I have received an explanation of how my health information will be used and disclosed for the purposes of this research study and that my protected health information may be disclosed to the study sponsor, study monitors, and regulatory authorities as necessary for study conduct and oversight.

I acknowledge receipt of the privacy practices information:

Questions and Contacts

For questions about study procedures or to report an adverse event, contact the study coordinator or principal investigator.

Certification and Consent

By signing below I certify that I have read (or been read) this agreement, my questions have been answered, I understand the risks and benefits described, and I voluntarily agree to participate in this lung study. I understand I may be contacted for additional information or follow-up as described above.

I confirm that study procedures, alternatives, and expected duration were explained to me:

Printed Name:

Relationship (if signing as guardian):

Signature:

Date:

Enter text✕

What the Healthcare Lung Study Agreement Covers

A Healthcare Lung Study Agreement is a legal document that defines the relationship between a research sponsor, clinical investigator or institution, and study participants or participating sites for a lung-focused clinical study. It sets out the study scope, participant eligibility, data use and sharing, privacy protections for health information, compensation or cost-recovery terms, responsibilities for safety reporting, intellectual property and publication rights, insurance and indemnification obligations, and the conditions for termination or amendment. The agreement supports regulatory compliance and documentation used in institutional review board (IRB) submissions and site contracting.

Why this agreement matters for clinical research

A clear Healthcare Lung Study Agreement reduces legal ambiguity, protects patient privacy under HIPAA, clarifies responsibilities between sponsor and site, and documents data-use and publication rights so the study can proceed with IRB and institutional approvals.

Why this agreement matters for clinical research

Who commonly prepares and signs this agreement

Typical parties include study sponsors (biotech, pharma), clinical trial sites, principal investigators, and institutional contracts or legal offices.

  • Study sponsors and contract research organizations managing funding, monitoring, and regulatory filings.
  • Clinical investigators and site administrators responsible for participant recruitment and protocol adherence.
  • Institutional officials or legal counsels who review indemnity, IP, and data-use terms.

Each signer’s role should be documented in the agreement and matching delegation logs so obligations and points of contact are clear for audits and reporting.

Roles with signing authority

Sponsor Signatory

Chief Medical Officer or authorized contracts manager signs for the study sponsor. This signer accepts sponsor obligations including funding, safety reporting, and regulatory compliance for the trial.

Site Signatory

Institutional official (e.g., research director or authorized signatory) signs for the site, confirming resources, IRB approvals, and adherence to protocol and data protection requirements.

Core data and privacy items to include

Participant ID: De-identified code
Protected Health: HIPAA-limited
Data Use Limits: Research-only
Retention Period: Specified term
Breach Response: Reporting plan
Data Transfer: Encryption required

Step-by-step: preparing and executing the agreement

Follow these sequential steps to complete the agreement accurately and keep the study moving toward IRB approval and site activation.

  • 01
    Drafting: Assemble protocol summary, budget, and HIPAA authorization text for the contract.
  • 02
    Internal review: Have legal and compliance review indemnity, IP, and data clauses.
  • 03
    Site negotiation: Resolve payment, liability, and insurance items with the site.
  • 04
    Execution: Collect authorized signatures and date the executed agreement.

How to configure an online signing workflow

Set up fields and authentication to mirror the paper process while ensuring compliance and clear auditability.

Field Recommended setting
Signature Block Require full name, title, date
Initials Enable for multi-page initialing
Authentication Email + SMS code or institutional SSO
Attachments Allow CVs, IRB approvals, and training certificates

Typical electronic execution flow

Electronic signing follows a predictable sequence; ensure each step records identity and intent to sign for legal validity.

  • Upload Document: Sender uploads final signed-ready PDF or DOCX
  • Place Fields: Add signature, initials, date and attachment fields
  • Authentication: Choose email, SMS code, or stronger verification
  • Complete & Archive: Signed copies and audit trail stored securely

Technical requirements for secure e-signing

Confirm vendor capabilities and integrations before e-signature roll-out.

  • PDF/DOCX Support: Must accept PDF and Word DOCX
  • Authentication Options: Email, SMS, KBA, SSO
  • Integrations: Works with EHR and document storage

Verify HIPAA BAA availability, audit trails, encryption (TLS 1.2/1.3 and AES-256 at rest), and integration with institutional systems before selecting a provider.

How this agreement differs from a standard clinical consent form

A Healthcare Lung Study Agreement governs contractual relationships and operational obligations; a participant consent form documents individual informed consent.

Criteria Healthcare Lung Study Agreement Participant Consent Form
Primary Purpose contractual terms informed consent
Main Signer institution/sponsor rep participant or legal guardian
Regulatory Focus contract compliance irb and human subjects protection
Retention institutional archive participant record at site

Typical eSignature vendor pricing and feature comparison

Comparing baseline plans and select features for common eSignature vendors; signNow is listed first per page requirements.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Common pitfalls to avoid

  • Using inconsistent party names across documents delays contracting and creates enforceability issues.
  • Failing to attach IRB approval or protocol to the agreement can prevent site activation and payments.
  • Omitting HIPAA BAA when PHI is exchanged risks regulatory noncompliance and administrative penalties.
  • Relying on weak signer authentication can undermine attribution and create disputes during audits.

Legal and operational risks

HIPAA Violation: Civil penalties possible
Contract Breach: Damages and injunction
Delayed Activation: Lost enrollment time
Invalid Signature: Enforceability risk
Data Loss: Regulatory exposure
Audit Findings: Corrective actions

Practical examples of agreement use

Realistic scenarios illustrate how this agreement functions in practice across research and institutional settings.

Multi-site Sponsor

A sponsor centralizes contracting to reduce variability in site terms and data sharing

  • Central template limits negotiation scope
  • The result: faster site activation and consistent data-use controls across sites, easing pooled data analysis.

Academic Medical Center

A large hospital uses the agreement to document budget and indemnity with a biotech partner

  • IRB approval is attached as an exhibit
  • This preserves institutional compliance, clarifies billing responsibility, and streamlines audits and invoicing.

Practical tips for accurate and efficient completion

Adopt standard clauses and checklists to reduce negotiation time and ensure regulatory alignment.

Use a Master Template
Maintain a vetted institutional template with approved HIPAA, indemnity, and IP clauses to speed negotiation.
Attach IRB Documents
Always include the IRB approval letter and final protocol as exhibits to avoid activation delays.
Define Payment Terms
Specify invoicing, timelines, and documentation required to trigger sponsor payments to sites.
Record Signer Authority
Keep delegation logs and board resolutions verifying signatory authority for audit purposes.

Time-sensitive deadlines to track

Monitor milestone dates, invoicing windows, and reporting obligations to remain compliant and avoid penalties.

Effective Date:

Date obligations begin; ensure executed copy is retained

Enrollment Targets:

Track milestones tied to payments or reporting

Safety Reporting:

Timelines for adverse event reports per protocol

Invoice Submission:

Sponsor payment windows and dispute periods

Agreement Renewal:

Deadlines for extensions or amendments

Frequently asked questions

Answers to common execution, compliance, and eSignature questions for Healthcare Lung Study Agreements.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users